Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",7.378256540937556e-07,19.14655870445344,270.3409515142571,"['CX3CR1', 'P2RY12', 'P2RY13', 'CHRM3', 'CYSLTR1', 'HRH2', 'GPR65']",0.00016493160606964328,0,0,7
2,Complement system WP2806,1.2172074248682162e-06,12.981240981240981,176.79088898353066,"['FCGR3A', 'CD93', 'C5AR1', 'ITGAX', 'SPP1', 'F13A1', 'VSIG4', 'CD55']",0.00016493160606964328,0,0,8
3,Monoamine GPCRs WP58,0.0007958059112799518,inf,inf,"['CHRM3', 'HRH2']",0.07188780065228897,0,0,2
4,"GPCRs, Other WP117",0.002307942309970203,14.938144329896907,90.69543344588128,"['CHRM3', 'ADGRE2', 'P2RY13']",0.1526164539952557,0,0,3
5,Inflammatory Response Pathway WP453,0.004598475421385894,34.702564102564104,186.77025705938658,"['IL4R', 'TNFRSF1B']",0.1526164539952557,0,0,2
6,Endochondral Ossification with Skeletal Dysplasias WP4808,0.0049240117152425916,6.6597582037996546,35.387502249105374,"['SPP1', 'ENPP1', 'PLAT', 'IGF1']",0.1526164539952557,0,0,4
7,Endochondral Ossification WP474,0.0049240117152425916,6.6597582037996546,35.387502249105374,"['SPP1', 'ENPP1', 'PLAT', 'IGF1']",0.1526164539952557,0,0,4
8,Toll-like Receptor Signaling Pathway WP75,0.00518323090767202,4.137973514012935,21.77536846446745,"['SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6']",0.1526164539952557,0,0,6
9,Apoptosis WP254,0.005633451969065082,4.870515046296297,25.224557598209667,"['CASP4', 'CASP1', 'BAX', 'IGF1', 'TNFRSF1B']",0.1526164539952557,0,0,5
10,Acute viral myocarditis WP4298,0.006914630385429297,4.612801535087719,22.94460884306906,"['CASP1', 'BAX', 'TLR5', 'AIF1', 'CD55']",0.1526164539952557,0,0,5
11,NOTCH1 regulation of endothelial cell calcification WP3413,0.007521724363733833,23.13162393162393,113.11271260595707,"['NOTCH1', 'PLAT']",0.1526164539952557,0,0,2
12,Apoptosis Modulation and Signaling WP1772,0.007626031066604254,4.493856837606837,21.912889633842987,"['CASP4', 'CASP1', 'BAX', 'TNFRSF1B', 'HSPA1A']",0.1526164539952557,0,0,5
13,MECP2 and Associated Rett Syndrome WP3584,0.007626031066604254,4.493856837606837,21.912889633842987,"['RBFOX1', 'CEBPD', 'BCL6', 'IGF1', 'FKBP5']",0.1526164539952557,0,0,5
14,Complement and Coagulation Cascades WP558,0.007884244855843468,8.707474226804123,42.16932969542757,"['C5AR1', 'PLAT', 'CD55']",0.1526164539952557,0,0,3
15,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.01006331255566547,4.171006944444445,19.18187236097095,"['HSPA5', 'PSMD5', 'CASP1', 'HSPA1B', 'HSPA1A']",0.16122955697492083,0,0,5
16,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.011073428770335887,17.346153846153847,78.11331873214473,"['SPP1', 'ENPP1']",0.16122955697492083,0,0,2
17,Macrophage markers WP4146,0.011073428770335887,17.346153846153847,78.11331873214473,"['CD163', 'CD83']",0.16122955697492083,0,0,2
18,Pyrimidine metabolism and related diseases WP4225,0.011073428770335887,17.346153846153847,78.11331873214473,"['DPYD', 'TYMP']",0.16122955697492083,0,0,2
19,Neovascularisation processes WP4331,0.011303917278684487,7.461340206185567,33.44624801446355,"['NOTCH1', 'CXCL12', 'HIF1A']",0.16122955697492083,0,0,3
20,TYROBP causal network in microglia WP3945,0.011956518464182544,3.980232007575758,17.61841208776059,"['DPYD', 'ITGAX', 'SPP1', 'TCIRG1', 'TNFRSF1B']",0.16201082518967347,0,0,5
21,7-oxo-C and 7beta-HC pathways WP5064,0.015216067711575796,13.874871794871796,58.07193451873513,"['DBP', 'ACOT7']",0.1874342886289564,0,0,2
22,Biomarkers for pyrimidine metabolism disorders WP4584,0.015216067711575796,13.874871794871796,58.07193451873513,"['DPYD', 'TYMP']",0.1874342886289564,0,0,2
23,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.019913721260655652,11.56068376068376,45.27564077415817,"['CYSLTR1', 'LTC4S']",0.22485910256823674,0,0,2
24,Fluoropyrimidine Activity WP1601,0.019913721260655652,11.56068376068376,45.27564077415817,"['DPYD', 'TYMP']",0.22485910256823674,0,0,2
25,Regulation of toll-like receptor signaling pathway WP1449,0.022573991056031906,2.9219022687609075,11.076805489908455,"['SPP1', 'LY96', 'MAP3K8', 'TLR5', 'IKBKE', 'MAP2K6']",0.24324196106739804,0,0,6
26,3q29 copy number variation syndrome WP4906,0.02357298160077695,3.987564766839378,14.94401332868632,"['TFRC', 'PXN', 'HIF1A', 'HAMP']",0.24324196106739804,0,0,4
27,Oxysterols derived from cholesterol WP4545,0.02513201073759094,9.907692307692308,36.49610336419662,"['DBP', 'ACOT7']",0.24324196106739804,0,0,2
28,Peptide GPCRs WP24,0.02513201073759094,9.907692307692308,36.49610336419662,"['CX3CR1', 'C5AR1']",0.24324196106739804,0,0,2
29,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.028280046762989973,inf,inf,['HRH2'],0.25324573075777157,0,0,1
30,"COVID-19, thrombosis and anticoagulation WP4927",0.028280046762989973,inf,inf,['F13A1'],0.25324573075777157,0,0,1
31,Cardiac Progenitor Differentiation WP2406,0.03083804101478399,8.667948717948718,30.155847792385437,"['NOTCH1', 'IGF1']",0.25324573075777157,0,0,2
32,Differentiation Pathway WP2848,0.03083804101478399,8.667948717948718,30.155847792385437,"['NOTCH1', 'IGF1']",0.25324573075777157,0,0,2
33,Iron metabolism in placenta WP2007,0.03083804101478399,8.667948717948718,30.155847792385437,"['TFRC', 'HAMP']",0.25324573075777157,0,0,2
34,TNF-alpha signaling pathway WP231,0.03216886716092399,3.0132004310344827,10.355635120065001,"['BAX', 'MAP3K8', 'PYGL', 'TNFRSF1B', 'MAP2K6']",0.2564047941356001,0,0,5
35,Amyotrophic lateral sclerosis (ALS) WP2447,0.03591006623745083,4.535634244733304,15.088865100659566,"['CASP1', 'BAX', 'MAP2K6']",0.27100252538393815,0,0,3
36,Gastric Cancer Network 2 WP2363,0.03700034479411702,7.703703703703703,25.397786440935327,"['PLAC8', 'RNF144B']",0.27100252538393815,0,0,2
37,Genes controlling nephrogenesis WP4823,0.03700034479411702,7.703703703703703,25.397786440935327,"['ROBO2', 'CXCL12']",0.27100252538393815,0,0,2
38,Spinal Cord Injury WP2431,0.04019720298864226,3.319516407599309,10.668785860141364,"['ZFP36', 'FCGR2A', 'TNFSF13', 'AIF1']",0.28666952657689615,0,0,4
39,Statin inhibition of cholesterol production WP430,0.043588828842409465,6.932307692307693,21.718603752751715,"['APOC1', 'PLTP']",0.28811152722665767,0,0,2
40,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.043588828842409465,6.932307692307693,21.718603752751715,"['SPP1', 'IGF1']",0.28811152722665767,0,0,2
41,Purinergic signaling WP4900,0.043588828842409465,6.932307692307693,21.718603752751715,"['P2RY12', 'P2RY13']",0.28811152722665767,0,0,2
42,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.04747103078815373,4.01050753370341,12.222565662668385,"['NOTCH1', 'CEBPD', 'SPP1']",0.30630117484737285,0,0,3
43,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.055764371258384154,34.53061224489796,99.6767601118383,['NOTCH1'],0.32852488284830667,0,0,1
44,Blood Clotting Cascade WP272,0.055764371258384154,34.53061224489796,99.6767601118383,['PLAT'],0.32852488284830667,0,0,1
45,Gene regulatory network modelling somitogenesis  WP2854,0.055764371258384154,34.53061224489796,99.6767601118383,['NOTCH1'],0.32852488284830667,0,0,1
46,Hfe effect on hepcidin production WP3924,0.055764371258384154,34.53061224489796,99.6767601118383,['HAMP'],0.32852488284830667,0,0,1
47,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.05793052551319205,5.775213675213675,16.45075865548448,"['FCGR2A', 'IKBKE']",0.3340249449803201,0,0,2
48,Pyrimidine metabolism WP4022,0.0653559386432268,3.4737113402061857,9.475961371931719,"['DPYD', 'ENPP1', 'TYMP']",0.3629738816322532,0,0,3
49,Immune response to tuberculosis WP4197,0.06562996383756607,5.3301775147929,14.517926672712195,"['OAS1', 'PTPN2']",0.3629738816322532,0,0,2
50,Notch Signaling Pathway Netpath WP61,0.07024656111769784,3.3611572996341867,8.92637307620489,"['NOTCH1', 'HIF1A', 'SAP30']",0.38073636125792226,0,0,3
51,Unfolded protein response WP4925,0.07364793885858263,4.948717948717949,12.908528475993503,"['XBP1', 'HSPA5']",0.3838190659745364,0,0,2
52,Photodynamic therapy-induced unfolded protein response WP3613,0.07364793885858263,4.948717948717949,12.908528475993503,"['XBP1', 'HSPA5']",0.3838190659745364,0,0,2
53,Insulin Signaling WP481,0.08207665324961756,2.073920481053341,5.185012063604368,"['SNAP25', 'PTPN1', 'XBP1', 'ENPP1', 'MAP3K8', 'MAP2K6']",0.385358157194152,0,0,6
54,EV release from cardiac cells and their functional effects WP3297,0.08247517755446795,17.262755102040817,43.07502620022366,['CXCL12'],0.385358157194152,0,0,1
55,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.08247517755446795,17.262755102040817,43.07502620022366,['HIF1A'],0.385358157194152,0,0,1
56,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.08247517755446795,17.262755102040817,43.07502620022366,['BAX'],0.385358157194152,0,0,1
57,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.08247517755446795,17.262755102040817,43.07502620022366,['HIF1A'],0.385358157194152,0,0,1
58,Peroxiredoxin 2 induced ovarian failure WP4873,0.08247517755446795,17.262755102040817,43.07502620022366,['BAX'],0.385358157194152,0,0,1
59,Lung fibrosis WP3624,0.09054472306757584,4.328846153846154,10.39750480802241,"['SPP1', 'IGF1']",0.4158918635815772,0,0,2
60,The influence of laminopathies on Wnt signaling WP4844,0.0993788240141749,4.073604826546003,9.405204922257719,"['CEBPD', 'SPP1']",0.42704310288482444,0,0,2
61,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.0993788240141749,4.073604826546003,9.405204922257719,"['BAX', 'HIF1A']",0.42704310288482444,0,0,2
62,Thiamine metabolic pathways WP4297,0.10843411618687816,11.506802721088436,25.563656927293277,['SLC25A19'],0.42704310288482444,0,0,1
63,Caloric restriction and aging WP4191,0.10843411618687816,11.506802721088436,25.563656927293277,['IGF1'],0.42704310288482444,0,0,1
64,Farnesoid X receptor pathway WP2879,0.10843411618687816,11.506802721088436,25.563656927293277,['FKBP5'],0.42704310288482444,0,0,1
65,"GPCRs, Class B Secretin-like WP334",0.10843411618687816,11.506802721088436,25.563656927293277,['ADGRE2'],0.42704310288482444,0,0,1
66,PTF1A related regulatory pathway WP4147,0.10843411618687816,11.506802721088436,25.563656927293277,['NOTCH1'],0.42704310288482444,0,0,1
67,Role of Osx and miRNAs in tooth development WP3971,0.10843411618687816,11.506802721088436,25.563656927293277,['NOTCH1'],0.42704310288482444,0,0,1
68,Toll-like Receptor Signaling related to MyD88 WP3858,0.10844196289093963,3.8467236467236465,8.545651040017898,"['TLR5', 'IKBKE']",0.42704310288482444,0,0,2
69,Cardiac Hypertrophic Response WP2795,0.10873053173082245,2.739148128052089,6.077848239601275,"['IGF1', 'IKBKE', 'MAP2K6']",0.42704310288482444,0,0,3
70,Oncostatin M Signaling Pathway WP2374,0.1147821769898224,2.6685170499603488,5.7765897195879035,"['PXN', 'JAK3', 'HIF1A']",0.4430634804913052,0,0,3
71,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.11771428263975636,3.6437246963562755,7.795730493206066,"['OAS1', 'IKBKE']",0.4430634804913052,0,0,2
72,Oxidative Damage WP3941,0.11771428263975636,3.6437246963562755,7.795730493206066,"['C5AR1', 'TNFRSF1B']",0.4430634804913052,0,0,2
73,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.12717685593963854,3.461025641025641,7.1372460708950385,"['LY96', 'PLAT']",0.4527808453974964,0,0,2
74,Hematopoietic Stem Cell Differentiation WP2849,0.12717685593963854,3.461025641025641,7.1372460708950385,"['NOTCH1', 'PIM1']",0.4527808453974964,0,0,2
75,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.13366224218376277,8.628826530612244,17.364989120553613,['CASP1'],0.4527808453974964,0,0,1
76,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.13366224218376277,8.628826530612244,17.364989120553613,['NOTCH1'],0.4527808453974964,0,0,1
77,Complement Activation WP545,0.13366224218376277,8.628826530612244,17.364989120553613,['CD55'],0.4527808453974964,0,0,1
78,GDNF/RET signaling axis WP4830,0.13366224218376277,8.628826530612244,17.364989120553613,['ROBO2'],0.4527808453974964,0,0,1
79,HIF1A and PPARG regulation of glycolysis WP2456,0.13366224218376277,8.628826530612244,17.364989120553613,['HIF1A'],0.4527808453974964,0,0,1
80,Nanomaterial-induced inflammasome activation WP3890,0.13366224218376277,8.628826530612244,17.364989120553613,['CASP1'],0.4527808453974964,0,0,1
81,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.14660148652147917,3.1454545454545455,6.039390208736127,"['BAX', 'MAP2K6']",0.47629763366921424,0,0,2
82,PPAR signaling pathway WP3942,0.14660148652147917,3.1454545454545455,6.039390208736127,"['ACSL1', 'PLTP']",0.47629763366921424,0,0,2
83,Vitamin D Receptor Pathway WP2877,0.15353933896898728,2.310652920962199,4.329697896124908,"['BCL6', 'SPP1', 'HIF1A']",0.47629763366921424,0,0,3
84,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.15800531254019423,1.6973566594304685,3.131837960784043,"['IL4R', 'ITGAX', 'SPP1', 'IGF1', 'JAK3', 'HIF1A']",0.47629763366921424,0,0,6
85,Selective expression of chemokine receptors during T-cell polarization WP4494,0.15818002594180547,6.90204081632653,12.727511589397652,['IL4R'],0.47629763366921424,0,0,1
86,Transcriptional cascade regulating adipogenesis WP4211,0.15818002594180547,6.90204081632653,12.727511589397652,['CEBPD'],0.47629763366921424,0,0,1
87,Cytokines and Inflammatory Response WP530,0.15818002594180547,6.90204081632653,12.727511589397652,['IL15'],0.47629763366921424,0,0,1
88,Fatty acid transporters WP5061,0.15818002594180547,6.90204081632653,12.727511589397652,['ACSL1'],0.47629763366921424,0,0,1
89,Genes targeted by miRNAs in adipocytes WP1992,0.15818002594180547,6.90204081632653,12.727511589397652,['IGF1'],0.47629763366921424,0,0,1
90,Osteoclast Signaling WP12,0.15818002594180547,6.90204081632653,12.727511589397652,['SPP1'],0.47629763366921424,0,0,1
91,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.16658168511251356,2.8824786324786325,5.166178504506216,"['BST2', 'MAP2K6']",0.49608391940100194,0,0,2
92,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.17674169057026737,2.766769230769231,4.794993649502957,"['XBP1', 'HSPA5']",0.5014474375849483,0,0,2
93,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.17674169057026737,2.766769230769231,4.794993649502957,"['OAS1', 'IKBKE']",0.5014474375849483,0,0,2
94,Development and heterogeneity of the ILC family WP3893,0.18200736823679192,5.750850340136054,9.797770351851202,['IL15'],0.5014474375849483,0,0,1
95,Differentiation of white and brown adipocyte WP2895,0.18200736823679192,5.750850340136054,9.797770351851202,['PLAC8'],0.5014474375849483,0,0,1
96,Nanomaterial induced apoptosis WP2507,0.18200736823679192,5.750850340136054,9.797770351851202,['BAX'],0.5014474375849483,0,0,1
97,Ferroptosis WP4313,0.18699596768487295,2.659960552268245,4.459871339184744,"['TFRC', 'ACSL1']",0.5014474375849483,0,0,2
98,Adipogenesis WP236,0.18851198308783626,2.078041237113402,3.467406523563311,"['CEBPD', 'IGF1', 'HIF1A']",0.5014474375849483,0,0,3
99,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.18851198308783626,2.078041237113402,3.467406523563311,"['IGF1', 'IKBKE', 'MAP2K6']",0.5014474375849483,0,0,3
100,Nuclear Receptors Meta-Pathway WP2882,0.20015596122746226,1.6527777777777777,2.6587548723934296,"['PDE4B', 'BAX', 'PLTP', 'FKBP5', 'HSPA1A']",0.5014474375849483,0,0,5
101,BMP Signaling Pathway in Eyelid Development WP3927,0.2051636153942043,4.928571428571429,7.806598364769478,['NOTCH1'],0.5014474375849483,0,0,1
102,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.2051636153942043,4.928571428571429,7.806598364769478,['RYR2'],0.5014474375849483,0,0,1
103,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.2051636153942043,4.928571428571429,7.806598364769478,['RAB27A'],0.5014474375849483,0,0,1
104,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.2051636153942043,4.928571428571429,7.806598364769478,['ACSL1'],0.5014474375849483,0,0,1
105,"NAD metabolism, sirtuins and aging WP3630",0.2051636153942043,4.928571428571429,7.806598364769478,['HIF1A'],0.5014474375849483,0,0,1
106,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.2051636153942043,4.928571428571429,7.806598364769478,['JAK3'],0.5014474375849483,0,0,1
107,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.2051636153942043,4.928571428571429,7.806598364769478,['IGF1'],0.5014474375849483,0,0,1
108,Omega-3/Omega-6 FA synthesis WP4723,0.2051636153942043,4.928571428571429,7.806598364769478,['ACSL1'],0.5014474375849483,0,0,1
109,Overview of nanoparticle effects WP3287,0.2051636153942043,4.928571428571429,7.806598364769478,['BAX'],0.5014474375849483,0,0,1
110,RalA downstream regulated genes WP2290,0.2051636153942043,4.928571428571429,7.806598364769478,['YBX3'],0.5014474375849483,0,0,1
111,Integrin-mediated Cell Adhesion WP185,0.21039682131222467,1.9595409453413732,3.054453859889544,"['PXN', 'ITGAX', 'MAP2K6']",0.5014474375849483,0,0,3
112,Breast cancer pathway WP4262,0.21781437284050975,1.922966781214204,2.9308169000283395,"['NOTCH1', 'BAX', 'IGF1']",0.5014474375849483,0,0,3
113,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.2181941177152288,2.3837312113174183,3.6289212755149687,"['RYR2', 'CTNNA3']",0.5014474375849483,0,0,2
114,Cytosolic DNA-sensing pathway WP4655,0.2181941177152288,2.3837312113174183,3.6289212755149687,"['CASP1', 'IKBKE']",0.5014474375849483,0,0,2
115,p53 transcriptional gene network WP4963,0.2181941177152288,2.3837312113174183,3.6289212755149687,"['NOTCH1', 'BAX']",0.5014474375849483,0,0,2
116,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.2252858001099913,1.887722586691659,2.813434295939718,"['NOTCH1', 'HIF1A', 'MAP2K6']",0.5014474375849483,0,0,3
117,Chemokine signaling pathway WP3929,0.22547392695290486,1.6901301655503602,2.5175346556813394,"['CX3CR1', 'CXCL12', 'PXN', 'JAK3']",0.5014474375849483,0,0,4
118,TP53 network WP1742,0.2276675746920943,4.311862244897959,6.380990059831415,['BAX'],0.5014474375849483,0,0,1
119,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2276675746920943,4.311862244897959,6.380990059831415,['BAX'],0.5014474375849483,0,0,1
120,Omega-9 FA synthesis WP4724,0.2276675746920943,4.311862244897959,6.380990059831415,['ACSL1'],0.5014474375849483,0,0,1
121,Osteopontin Signaling WP1434,0.2276675746920943,4.311862244897959,6.380990059831415,['SPP1'],0.5014474375849483,0,0,1
122,PPAR-alpha pathway WP2878,0.2276675746920943,4.311862244897959,6.380990059831415,['PLTP'],0.5014474375849483,0,0,1
123,Allograft Rejection WP2328,0.23923665685044124,2.2292803970223325,3.188544257112724,"['CXCL12', 'CD55']",0.5014474375849483,0,0,2
124,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.23923665685044124,2.2292803970223325,3.188544257112724,"['HSPA5', 'YBX3']",0.5014474375849483,0,0,2
125,Sleep regulation WP3591,0.24953752901133802,3.8321995464852607,5.31965231155729,['PER3'],0.5014474375849483,0,0,1
126,Apoptosis Modulation by HSP70 WP384,0.24953752901133802,3.8321995464852607,5.31965231155729,['HSPA1A'],0.5014474375849483,0,0,1
127,Autosomal recessive Osteopetrosis pathways WP4788,0.24953752901133802,3.8321995464852607,5.31965231155729,['TCIRG1'],0.5014474375849483,0,0,1
128,Canonical and non-canonical Notch signaling WP3845,0.24953752901133802,3.8321995464852607,5.31965231155729,['NOTCH1'],0.5014474375849483,0,0,1
129,Vitamin B12 metabolism WP1533,0.24953752901133802,3.8321995464852607,5.31965231155729,['PLAT'],0.5014474375849483,0,0,1
130,Development of ureteric collection system WP5053,0.24953752901133802,3.8321995464852607,5.31965231155729,['ROBO2'],0.5014474375849483,0,0,1
131,Eicosanoid Synthesis WP167,0.24953752901133802,3.8321995464852607,5.31965231155729,['LTC4S'],0.5014474375849483,0,0,1
132,Gastric Cancer Network 1 WP2361,0.24953752901133802,3.8321995464852607,5.31965231155729,['NOTCH1'],0.5014474375849483,0,0,1
133,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.24953752901133802,3.8321995464852607,5.31965231155729,['MAP2K6'],0.5014474375849483,0,0,1
134,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.24953752901133802,3.8321995464852607,5.31965231155729,['OAS1'],0.5014474375849483,0,0,1
135,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.24979853901833213,2.159294871794872,2.9951590609057783,"['CXCL12', 'IKBKE']",0.5014474375849483,0,0,2
136,Endometrial cancer WP4155,0.26037436502369493,2.0935508935508937,2.8171549758331023,"['BAX', 'CTNNA3']",0.5113148762421835,0,0,2
137,IL-4 signaling pathway WP395,0.26037436502369493,2.0935508935508937,2.8171549758331023,"['IL4R', 'JAK3']",0.5113148762421835,0,0,2
138,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.26037436502369493,2.0935508935508937,2.8171549758331023,"['PXN', 'BAX']",0.5113148762421835,0,0,2
139,Hepatitis B infection WP4666,0.26248612531798504,1.5734809232218558,2.1046205086286194,"['BAX', 'IKBKE', 'JAK3', 'MAP2K6']",0.511753524900532,0,0,4
140,Angiogenesis WP1539,0.27079125144616584,3.448469387755102,4.505104701921993,['HIF1A'],0.5131778261672094,0,0,1
141,Imatinib and Chronic Myeloid Leukemia WP3640,0.27079125144616584,3.448469387755102,4.505104701921993,['PIM1'],0.5131778261672094,0,0,1
142,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.27079125144616584,3.448469387755102,4.505104701921993,['IL4R'],0.5131778261672094,0,0,1
143,Pre-implantation embryo WP3527,0.27079125144616584,3.448469387755102,4.505104701921993,['ZFP36'],0.5131778261672094,0,0,1
144,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.28153160573232194,1.9733333333333334,2.5012208414956683,"['MAP3K8', 'MAP2K6']",0.5265458083105773,0,0,2
145,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.2914460193600981,3.1345083487940633,3.8645368247161724,['MAP2K6'],0.5265458083105773,0,0,1
146,Fatty Acid Biosynthesis WP357,0.2914460193600981,3.1345083487940633,3.8645368247161724,['ACSL1'],0.5265458083105773,0,0,1
147,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2914460193600981,3.1345083487940633,3.8645368247161724,['HIF1A'],0.5265458083105773,0,0,1
148,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2914460193600981,3.1345083487940633,3.8645368247161724,['PXN'],0.5265458083105773,0,0,1
149,Monoamine Transport WP727,0.2914460193600981,3.1345083487940633,3.8645368247161724,['NECTIN2'],0.5265458083105773,0,0,1
150,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2914460193600981,3.1345083487940633,3.8645368247161724,['BAX'],0.5265458083105773,0,0,1
151,Synaptic Vesicle Pathway WP2267,0.30264080269469495,1.8661122661122662,2.2303935155213037,"['SNAP25', 'SYN3']",0.5309531335808153,0,0,2
152,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.30264080269469495,1.8661122661122662,2.2303935155213037,"['PIM1', 'MAP2K6']",0.5309531335808153,0,0,2
153,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.31151862818948206,2.872874149659864,3.3506220342445068,['TLR5'],0.5309531335808153,0,0,1
154,Transcription factor regulation in adipogenesis WP3599,0.31151862818948206,2.872874149659864,3.3506220342445068,['CEBPD'],0.5309531335808153,0,0,1
155,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.31151862818948206,2.872874149659864,3.3506220342445068,['BCL6'],0.5309531335808153,0,0,1
156,Folate Metabolism WP176,0.31151862818948206,2.872874149659864,3.3506220342445068,['PLAT'],0.5309531335808153,0,0,1
157,Heart Development WP1591,0.31151862818948206,2.872874149659864,3.3506220342445068,['NOTCH1'],0.5309531335808153,0,0,1
158,IL-9 signaling pathway WP22,0.31151862818948206,2.872874149659864,3.3506220342445068,['JAK3'],0.5309531335808153,0,0,1
159,SARS coronavirus and innate immunity WP4912,0.31151862818948206,2.872874149659864,3.3506220342445068,['IKBKE'],0.5309531335808153,0,0,1
160,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.3254411694578394,1.5238781079442085,1.7106652919357082,"['RYR2', 'SNAP25', 'HIF1A']",0.5512159807692155,0,0,3
161,White fat cell differentiation WP4149,0.33102540483827303,2.6514913657770802,2.931383204727997,['CEBPD'],0.553752374760321,0,0,1
162,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.33102540483827303,2.6514913657770802,2.931383204727997,['RAB27A'],0.553752374760321,0,0,1
163,Pathogenic Escherichia coli infection WP2272,0.334084762448325,1.7253846153846153,1.8916436058989246,"['LY96', 'TLR5']",0.5554415375674606,0,0,2
164,miRNA regulation of p53 pathway in prostate cancer WP3982,0.34998222048777256,2.461734693877551,2.5845086021466783,['BAX'],0.5748192833465839,0,0,1
165,SARS-CoV-2 mitochondrial interactions WP5038,0.34998222048777256,2.461734693877551,2.5845086021466783,['IKBKE'],0.5748192833465839,0,0,1
166,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.3548253042637694,1.6427350427350427,1.7020865855606595,"['NOTCH1', 'MGLL']",0.5792629967197681,0,0,2
167,Bladder cancer WP2828,0.36840450339438174,2.297278911564626,2.2940024186154244,['TYMP'],0.590755150413476,0,0,1
168,Vitamin D in inflammatory diseases WP4482,0.36840450339438174,2.297278911564626,2.2940024186154244,['MAP2K6'],0.590755150413476,0,0,1
169,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.36840450339438174,2.297278911564626,2.2940024186154244,['PTPN1'],0.590755150413476,0,0,1
170,Non-small cell lung cancer WP4255,0.37533570433816843,1.5675990675990676,1.5361443174403275,"['BAX', 'JAK3']",0.5983292698567274,0,0,2
171,16p11.2 proximal deletion syndrome WP4949,0.3955771937822241,1.4989966555183947,1.3901834848456096,"['MVP', 'MAP2K6']",0.6181020715928185,0,0,2
172,Aryl Hydrocarbon Receptor Pathway WP2873,0.4037050430698482,2.0264105642256904,1.8380977686974564,['BAX'],0.6181020715928185,0,0,1
173,TLR4 Signaling and Tolerance WP3851,0.4037050430698482,2.0264105642256904,1.8380977686974564,['IKBKE'],0.6181020715928185,0,0,1
174,Fatty acid beta-oxidation WP143,0.4037050430698482,2.0264105642256904,1.8380977686974564,['ACSL1'],0.6181020715928185,0,0,1
175,IL-7 signaling pathway WP205,0.4037050430698482,2.0264105642256904,1.8380977686974564,['JAK3'],0.6181020715928185,0,0,1
176,IL17 signaling pathway WP2112,0.4037050430698482,2.0264105642256904,1.8380977686974564,['CEBPD'],0.6181020715928185,0,0,1
177,Nanoparticle-mediated activation of receptor signaling WP2643,0.4037050430698482,2.0264105642256904,1.8380977686974564,['PXN'],0.6181020715928185,0,0,1
178,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.41551599835899583,1.4361111111111111,1.2612418375671415,"['BAX', 'IGF1']",0.6262959654418478,0,0,2
179,Signal transduction through IL1R WP4496,0.4206120505919421,1.913548752834467,1.657218114867173,['MAP2K6'],0.6262959654418478,0,0,1
180,Type II interferon signaling (IFNG) WP619,0.4206120505919421,1.913548752834467,1.657218114867173,['OAS1'],0.6262959654418478,0,0,1
181,Notch Signaling WP268,0.4206120505919421,1.913548752834467,1.657218114867173,['NOTCH1'],0.6262959654418478,0,0,1
182,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.4206120505919421,1.913548752834467,1.657218114867173,['BAX'],0.6262959654418478,0,0,1
183,Hippo-Merlin Signaling Dysregulation WP4541,0.4253625981452764,1.4065934065934067,1.2023747540334178,"['ITGAX', 'CDH12']",0.6272081215095388,0,0,2
184,Regulation of Actin Cytoskeleton WP51,0.4258534847149636,1.276823214967545,1.0899728092445164,"['CHRM3', 'PXN', 'PFN1']",0.6272081215095388,0,0,3
185,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.43340513903045597,1.261063615790797,1.0543530092876494,"['PTPN1', 'MAP3K8', 'MAP2K6']",0.6333604041438745,0,0,3
186,Prolactin Signaling Pathway WP2037,0.43512290664270686,1.3782564102564103,1.1468840187816258,"['PTPN1', 'PXN']",0.6333604041438745,0,0,2
187,Glycerophospholipid Biosynthetic Pathway WP2533,0.4370420500918986,1.8125671321160044,1.5003086955779665,['PGS1'],0.6333604041438745,0,0,1
188,Melatonin metabolism and effects WP3298,0.4530084328448501,1.7216836734693877,1.3633058132085323,['PER3'],0.6515081900492798,0,0,1
189,Thermogenesis WP4321,0.45437287055097375,1.324852071005917,1.0450924884758575,"['ACSL1', 'MGLL']",0.6515081900492798,0,0,2
190,IL-18 signaling pathway WP4754,0.4610748102136309,1.1581834806461444,0.8966598262468269,"['NRN1', 'CD83', 'SPP1', 'BAX']",0.6544848587137965,0,0,4
191,Leptin signaling pathway WP2034,0.46385721779196837,1.299661344944364,0.9983718951728794,"['PTPN1', 'BAX']",0.6544848587137965,0,0,2
192,Type 2 papillary renal cell carcinoma WP4241,0.4685242162010204,1.6394557823129252,1.2429820751852387,['HIF1A'],0.6544848587137965,0,0,1
193,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4685242162010204,1.6394557823129252,1.2429820751852387,['CASP1'],0.6544848587137965,0,0,1
194,Prion disease pathway WP3995,0.4685242162010204,1.6394557823129252,1.2429820751852387,['HSPA5'],0.6544848587137965,0,0,1
195,Senescence and Autophagy in Cancer WP615,0.47324463598098016,1.275403608736942,0.954184056798408,"['PLAT', 'IGF1']",0.6576886992351058,0,0,2
196,Focal Adhesion WP306,0.47789194186251005,1.174027647610122,0.8668675397860617,"['PXN', 'SPP1', 'IGF1']",0.6585736511391154,0,0,3
197,T-cell receptor (TCR) signaling pathway WP69,0.4825330051652681,1.2520279720279721,0.9123602403642143,"['CD83', 'MAP3K8']",0.6585736511391154,0,0,2
198,Integrated Cancer Pathway WP1971,0.4836020537885017,1.5647031539888683,1.136745752910037,['BAX'],0.6585736511391154,0,0,1
199,Neural Crest Differentiation WP2064,0.4836020537885017,1.5647031539888683,1.136745752910037,['NOTCH1'],0.6585736511391154,0,0,1
200,Target Of Rapamycin (TOR) Signaling WP1471,0.49825424561578324,1.4964507542147294,1.0424946346891946,['PRR5'],0.6618965713817513,0,0,1
201,Disruption of postsynaptic signaling by CNV WP4875,0.49825424561578324,1.4964507542147294,1.0424946346891946,['RYR2'],0.6618965713817513,0,0,1
202,Glycogen Synthesis and Degradation WP500,0.49825424561578324,1.4964507542147294,1.0424946346891946,['PYGL'],0.6618965713817513,0,0,1
203,Hepatitis C and Hepatocellular Carcinoma WP3646,0.49825424561578324,1.4964507542147294,1.0424946346891946,['HIF1A'],0.6618965713817513,0,0,1
204,MAPK Cascade WP422,0.49825424561578324,1.4964507542147294,1.0424946346891946,['MAP2K6'],0.6618965713817513,0,0,1
205,MAPK Signaling Pathway WP382,0.5042486057515466,1.0926885434657456,0.7481484029034446,"['MAP3K8', 'HSPA1B', 'MAP2K6', 'HSPA1A']",0.6633561755275201,0,0,4
206,PI3K-Akt signaling pathway WP4172,0.5042486057515466,1.0926885434657456,0.7481484029034446,"['IL4R', 'SPP1', 'IGF1', 'JAK3']",0.6633561755275201,0,0,4
207,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5124927480776077,1.4338860544217686,0.9585079727899171,['IGF1'],0.6677189169664985,0,0,1
208,p38 MAPK Signaling Pathway WP400,0.5124927480776077,1.4338860544217686,0.9585079727899171,['MAP2K6'],0.6677189169664985,0,0,1
209,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5263291832836478,1.376326530612245,0.883365507674897,['ACSL1'],0.6792152793803264,0,0,1
210,Phosphodiesterases in neuronal function WP4222,0.5263291832836478,1.376326530612245,0.883365507674897,['PDE4B'],0.6792152793803264,0,0,1
211,DNA damage response (only ATM dependent) WP710,0.5360880102584692,1.1278688524590164,0.7031776557461002,"['BCL6', 'BAX']",0.6885300984836263,0,0,2
212,CAMKK2  Pathway WP4874,0.5397748485888987,1.3231946624803768,0.8158860279483988,['CHRM3'],0.6899952073942998,0,0,1
213,Signaling of Hepatocyte Growth Factor Receptor WP313,0.5655374878309316,1.2283163265306123,0.7001141357928135,['PXN'],0.7118375626140503,0,0,1
214,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5655374878309316,1.2283163265306123,0.7001141357928135,['BAX'],0.7118375626140503,0,0,1
215,Glucocorticoid Receptor Pathway WP2880,0.5655374878309316,1.2283163265306123,0.7001141357928135,['PDE4B'],0.7118375626140503,0,0,1
216,Ectoderm Differentiation WP2858,0.5777400385412348,1.0416472416472415,0.5714802509430825,"['PLCXD3', 'PIM1']",0.7118375626140503,0,0,2
217,TGF-beta Receptor Signaling WP560,0.5778755120852068,1.1857846586910625,0.6502805247920174,['SPP1'],0.7118375626140503,0,0,1
218,Genotoxicity pathway WP4286,0.5778755120852068,1.1857846586910625,0.6502805247920174,['CEBPD'],0.7118375626140503,0,0,1
219,Microglia Pathogen Phagocytosis Pathway WP3937,0.5778755120852068,1.1857846586910625,0.6502805247920174,['FCER1G'],0.7118375626140503,0,0,1
220,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5778755120852068,1.1857846586910625,0.6502805247920174,['CXCL12'],0.7118375626140503,0,0,1
221,Selenium Micronutrient Network WP15,0.5898648835791559,1.1460884353741496,0.6049762806081518,['PLAT'],0.7200602858105912,0,0,1
222,IL-2 signaling pathway WP49,0.5898648835791559,1.1460884353741496,0.6049762806081518,['JAK3'],0.7200602858105912,0,0,1
223,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.6128366082100049,1.074139030612245,0.5259596127047441,['SPP1'],0.7348615965704041,0,0,1
224,DNA damage response WP707,0.6128366082100049,1.074139030612245,0.5259596127047441,['BAX'],0.7348615965704041,0,0,1
225,G13 Signaling Pathway WP524,0.6128366082100049,1.074139030612245,0.5259596127047441,['PFN1'],0.7348615965704041,0,0,1
226,miRNA regulation of DNA damage response WP1530,0.6128366082100049,1.074139030612245,0.5259596127047441,['BAX'],0.7348615965704041,0,0,1
227,RANKL/RANK signaling pathway WP2018,0.6238377531118242,1.04143475572047,0.4914165646227264,['MAP2K6'],0.7417373562250257,0,0,1
228,B Cell Receptor Signaling Pathway WP23,0.6240447129863684,0.953988603988604,0.449837354297949,"['BCL6', 'MAP2K6']",0.7417373562250257,0,0,2
229,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6345278439603282,1.0106542617046819,0.4597204572854165,['NOTCH1'],0.7509041297521788,0,0,1
230,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6449156320026348,0.9816326530612245,0.43057919840067543,['PFN1'],0.7533281735892846,0,0,1
231,Modulators of TCR signaling and T cell activation WP5072,0.6449156320026348,0.9816326530612245,0.43057919840067543,['MAP3K8'],0.7533281735892846,0,0,1
232,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6449156320026348,0.9816326530612245,0.43057919840067543,['JAK3'],0.7533281735892846,0,0,1
233,Ebola Virus Pathway on Host WP4217,0.6526854542149229,0.9032388663967611,0.38537585783898515,"['BST2', 'IKBKE']",0.7553515234498978,0,0,2
234,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6550096236558154,0.9542233560090703,0.4037370078339803,['MAP3K8'],0.7553515234498978,0,0,1
235,Exercise-induced Circadian Regulation WP410,0.6550096236558154,0.9542233560090703,0.4037370078339803,['ERC2'],0.7553515234498978,0,0,1
236,Retinoblastoma gene in cancer WP2446,0.6648180871748139,0.9282956425813569,0.37896911085885526,['SAP30'],0.7614524792433068,0,0,1
237,Calcium Regulation in the Cardiac Cell WP536,0.6730123731633344,0.8685491723466408,0.34393814553301205,"['CHRM3', 'RYR2']",0.7614524792433068,0,0,2
238,Small cell lung cancer WP4658,0.6743490591084637,0.9037325456498388,0.3560773198947251,['BAX'],0.7614524792433068,0,0,1
239,DNA IR-damage and cellular response via ATR WP4016,0.6743490591084637,0.9037325456498388,0.3560773198947251,['BCL6'],0.7614524792433068,0,0,1
240,IL-3 signaling pathway WP286,0.6743490591084637,0.9037325456498388,0.3560773198947251,['CD69'],0.7614524792433068,0,0,1
241,TGF-beta Signaling Pathway WP366,0.6923689568492621,0.8363977485928705,0.3074901659377797,"['LIMK2', 'MAP2K6']",0.7633210783480794,0,0,2
242,Myometrial relaxation and contraction pathways WP289,0.6923689568492621,0.8363977485928705,0.3074901659377797,"['RYR2', 'PDE4B']",0.7633210783480794,0,0,2
243,Melanoma WP4685,0.6926095558974976,0.8582908163265306,0.3152406468695864,['BAX'],0.7633210783480794,0,0,1
244,MET in type 1 papillary renal cell carcinoma WP4205,0.6926095558974976,0.8582908163265306,0.3152406468695864,['JAK3'],0.7633210783480794,0,0,1
245,Osteoblast differentiation WP4787,0.6926095558974976,0.8582908163265306,0.3152406468695864,['NOTCH1'],0.7633210783480794,0,0,1
246,AGE/RAGE pathway WP2324,0.7013540535375342,0.8372324539571926,0.29700189211349987,['HIF1A'],0.7633210783480794,0,0,1
247,IL-1 signaling pathway WP195,0.7013540535375342,0.8372324539571926,0.29700189211349987,['MAP2K6'],0.7633210783480794,0,0,1
248,Interferon type I signaling pathways WP585,0.7013540535375342,0.8372324539571926,0.29700189211349987,['MAP2K6'],0.7633210783480794,0,0,1
249,NRF2 pathway WP2884,0.7013540535375342,0.8372324539571926,0.29700189211349987,['HSPA1A'],0.7633210783480794,0,0,1
250,Pathways affected in adenoid cystic carcinoma WP3651,0.7181074197309052,0.7980541053630754,0.2642645331935957,['NOTCH1'],0.7784284429883013,0,0,1
251,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7261300373786088,0.7798005565862709,0.24955658186203858,['BAX'],0.7808779370222341,0,0,1
252,ESC Pluripotency Pathways WP3931,0.7261300373786088,0.7798005565862709,0.24955658186203858,['MAP2K6'],0.7808779370222341,0,0,1
253,Head and Neck Squamous Cell Carcinoma WP4674,0.7339254573251186,0.7623582766439909,0.23583386507062007,['NOTCH1'],0.7830464525004219,0,0,1
254,Proteasome Degradation WP183,0.7339254573251186,0.7623582766439909,0.23583386507062007,['PSMD5'],0.7830464525004219,0,0,1
255,Pathways in clear cell renal cell carcinoma WP4018,0.7488601333038557,0.7297003907946157,0.21103157919847257,['HIF1A'],0.7927386567396285,0,0,1
256,Pathways Regulating Hippo Signaling WP4540,0.7488601333038557,0.7297003907946157,0.21103157919847257,['CDH12'],0.7927386567396285,0,0,1
257,Circadian rhythm related genes WP3594,0.7554112714680196,0.736255858836504,0.20651457605023502,"['PER3', 'DBP']",0.7965620800304798,0,0,2
258,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7629605415528165,0.6997084548104956,0.1893053974857658,['MAP2K6'],0.7983100647135646,0,0,1
259,Glioblastoma signaling pathways WP2261,0.7629605415528165,0.6997084548104956,0.1893053974857658,['MAP2K6'],0.7983100647135646,0,0,1
260,Pancreatic adenocarcinoma pathway WP4263,0.7948597204908073,0.634448223733938,0.14566273428001258,['BAX'],0.8284884009731108,0,0,1
261,Nonalcoholic fatty liver disease WP4396,0.8153146601022248,0.6447024673439767,0.13163609392257442,"['XBP1', 'BAX']",0.845347551202402,0,0,2
262,G Protein Signaling Pathways WP35,0.817273278284241,0.590341308937368,0.11912010247809461,['PDE4B'],0.845347551202402,0,0,1
263,7q11.23 copy number variation syndrome WP4932,0.8275486596161109,0.5704931972789116,0.10798715708599095,['SNAP25'],0.8494912377119928,0,0,1
264,Androgen receptor signaling pathway WP138,0.8275486596161109,0.5704931972789116,0.10798715708599095,['LIMK2'],0.8494912377119928,0,0,1
265,Endoderm differentiation WP2853,0.846406270708741,0.5345184948979592,0.08913406416147414,['NOTCH1'],0.8623161630152962,0,0,1
266,Gastrin signaling pathway WP4659,0.846406270708741,0.5345184948979592,0.08913406416147414,['PXN'],0.8623161630152962,0,0,1
267,EGF/EGFR signaling pathway WP437,0.8586484554240976,0.578096479791395,0.0880994115752908,"['PLSCR1', 'LIMK2']",0.8715121026963688,0,0,2
268,VEGFA-VEGFR2 Signaling Pathway WP3888,0.896808520680394,0.6244234317343174,0.06800777056501604,"['PTPN1', 'PXN', 'PFN1', 'MAP2K6', 'HSPA1A']",0.9068474220312939,0,0,5
269,Integrated breast cancer pathway WP1984,0.9188602714455059,0.39647603227337447,0.03355028250492045,['BAX'],0.9256919463261416,0,0,1
270,mRNA Processing WP411,0.9393312628197806,0.3546449829931973,0.0221961937205185,['SNRPG'],0.942810267496891,0,0,1
271,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9475481004719144,0.3368357243887654,0.018147892894204518,['SPP1'],0.9475481004719144,0,0,1
